schizandrin b has been researched along with quercetin in 3 studies
Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (quercetin) | Trials (quercetin) | Recent Studies (post-2010) (quercetin) |
---|---|---|---|---|---|
321 | 1 | 218 | 12,403 | 239 | 7,510 |
9 | 0 | 7 | 12,403 | 239 | 7,510 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hou, JW; Li, XJ; Xin, WJ; Yan, LJ; Zhao, BL | 1 |
Du, X; Gao, Z; Li, L; Li, Q; Shen, L; Zhang, J; Zhao, Z; Zou, Y | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
3 other study(ies) available for schizandrin b and quercetin
Article | Year |
---|---|
Effects of oxygen radicals on the conformation of sulfhydryl groups on human polymorphonuclear leukocyte membranes.
Topics: Cell Membrane; Cyclooctanes; Electron Spin Resonance Spectroscopy; Fluorometry; Free Radicals; Humans; Lignans; Lipid Peroxidation; Luminescent Measurements; Malondialdehyde; Membrane Proteins; Neutrophils; Oxygen; Polycyclic Compounds; Quercetin; Respiratory Burst; Sulfhydryl Compounds; Tetradecanoylphorbol Acetate | 1991 |
Heat shock proteins 27 and 70 contribute to the protection of Schisandrin B against d-galactosamine-induced liver injury in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclooctanes; Galactosamine; Gene Expression; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Lignans; Liver; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds; Protective Agents; Quercetin; Schisandra | 2016 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |